| post date: | dec 16,2021 |
| expiry date: | jun 14,2022 |
| detailed description: | cas no. :114-07-8 |
| cas registry number: | 114-07-8 |
| synonyms: | ;abomacetin;ak-mycin;aknin;drmysin;e-base;e.e.s;emgel;emu;e-mycin;ergel;eritocina;eritrocina;erthrogran;eryacne;eryc;erycen;erycette;erycin;erycinum;ery derm;erymax;ery-ped;ery-tab;erythro;erythroguent;erythromast;erythromast 36;erythromid;ilocap;ilosone;ilotycin;inderm;l-alpha-egg-phosphatidylcholine;p.c.e.;pediamycin;retcin;robimycin;statcin;staticin;stiemycin;torlamicina;torlamicna;t-stat;wintrocin;wyamycin-s;6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-{[(2r,3s,4r,6s)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(2s,3r,4s,6r)-4-(dimethylamino)-2-{[(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2h-pyran-3-yl propanoate (non-preferred name);(2s,3r,4s,6r)-4-(dimethylamino)-2-{[(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2h-pyran-3-yl ethyl butanedioate (non-preferred name);(3r,7r,9r,11r,13s,14r)-6-{[(3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);abboticin; |
| molecular formula: | c37h67no13 |
| molecular weight: | 733.9268 |
| molecular structure: | 
|
| hazard symbols: | |
| risk codes: | r42/43:; |
| safety description: | s24:; s37:; s45:; |
